✦ LIBER ✦

PP-4-23 CA 15-3, CEA and TPS for Monitoring metastatic breast cancer patients — a multicenter study

✍ Scribed by A. van Dalen; V. Barak; A. Cremaschi; M. Gion; R. Molina; M. Namer; P. Stieber; C. Sturgeon; R. Einarsson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CEA, MCA, CA 15.3 and CA 549 and their c

✍ A. Martoni; C. Zamagni; B. Bellanova; L. Zanichelli; F. Vecchi; N. Cacciari; E. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Kinetics of CEA and CA15-3 correlate wit

✍ Dorit Di Gioia; Volker Heinemann; Dorothea Nagel; Michael Untch; Steffen Kahlert 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 774 KB

Clinical significance of a serum CA 15-3

✍ Shih-Chung Wu; Fong-Fu Chou; Kun-Ming Rau 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 129 KB

Clinical significance of a serum CA15-3

✍ Hyo Song Kim; Yeon Hee Park; Min Jae Park; Myung Hee Chang; Hyun Jung Jun; Kyoun 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 279 KB

Immunotherapy prolongs the serum CEA–TPA

✍ A. Nicolini; A. Carpi; P. Ferrari; G. Rossi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Significance of serum carcinoembryonic a

✍ Junichi Kurebayashi; Yutaka Yamamoto; Katsuhiro Tanaka; Norio Kohno; Masafumi Ku 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 646 KB